Skip to Content

Cyanokit EMD Pharmaceuticals and Dey, LP - Treatment for Cyanide Poisoning

Cyanokit contains hydroxocobalamin, an antidote indicated for the treatment of known or suspected cyanide poisoning.

Posted: December 2006

Related Articles:

EMD Pharmaceuticals Announces Submission of New Drug Application for Cyanokit for Treatment of Cyanide Poisoning - June 20, 2006

Cyanokit (hydroxocobalamin) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Loading...

Approval History Drug history at FDA

Loading...

Recently Approved

Gemtesa
Gemtesa (vibegron) is a once-daily beta-3 adrenergic agonist indicated for the...
Ebanga
Ebanga (ansuvimab-zykl) is a monoclonal antibody for the treatment of Zaire...
Orgovyx
Orgovyx (relugolix) is an oral gonadotropin-releasing hormone (GnRH)...
Riabni
Riabni (rituximab-arrx) is a CD20-directed cytolytic antibody biosimilar to...

More drug approvals

Subscribe to our newsletters

Stay up to date

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 6 Jan 2021), Cerner Multum™ (updated 4 Jan 2021), ASHP (updated 6 Jan 2021) and others.